SLPW: A virulent bacteriophage targeting methicillin-resistant staphylococcus aureus in vitro and in vivo

Frontiers in Microbiology

Volumn 7, Issue JUN, 2016, Pages

  Wang, Zhaofei ^a   Zheng, Panpan ^a   Ji, Wenhui ^a   Fu, Qiang ^a   Wang, Hengan ^a   Yan, Yaxian ^a   Sun, Jianhe ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Infection; MRSA; Phage SLPW; Staphylococcus aureus; Therapy

Indexed keywords

DOUBLE STRANDED DNA; GENOMIC DNA; INTEGRASE; RESTRICTION ENDONUCLEASE; STAPHYLOCOCCUS PROTEIN A;

ABDOMINAL INFECTION; ARTICLE; BACTERIOPHAGE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GROWTH CURVE; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; LYSOGENIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR GENETICS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OPEN READING FRAME; PODOVIRIDAE; REPRESSOR GENE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET RADIATION;

EID: 84980047678     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00934     Document Type: Article

References (38)

1. Ackermann, H. W., Tremblay, D., and Moineau, S. (2004). Long-term bateriophage preservation. WFCC Newslett. 38, 35-40.
2. Adams, M. E. (1959). Bacteriophage. New York, NY: Interscience Publishers, 450-451.
3. Adams, M. J., Lefkowitz, E. J., King, A. M. Q., and Carstens, E. B. (2014). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2014). Arch. Virol. 159, 2831-2841. doi: 10.1007/s00705-014-2114-3.
4. Biswas, A., Mandal, S., and Sau, S. (2014). The N-terminal domain of the repressor of Staphylococcus aureus phage Phi11 possesses an unusual dimerization ability and DNA binding affinity. PLoS ONE 9:e95012. doi: 10.1371/journal.pone.0095012.
5. Borysowski, J., Lobocka, M., Miedzybrodzki, R., Weber-Dabrowska, B., and Gorski, A. (2011). Potential of bacteriophages and their lysins in the treatment of MRSA current status and future perspectives. Biodrugs 25, 347-355. doi: 10.2165/11595610-000000000-00000.
6. Capparelli, R., Parlato, M., Borriello, G., Salvatore, P., and Iannelli, D. (2007). Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51, 2765-2773. doi: 10.1128/AAC.01513-06.
7. Chhibber, S., Kaur, T., and Kaur, S. (2013). Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS ONE 8:e56022. doi: 10.1371/journal.pone.0056022.
8. Endersen, L., O'Mahony, J., Hill, C., Ross, R. P., McAuliffe, O., and Coffey, A. (2014). Phage therapy in the food industry. Annu. Rev. Food Sci. Technol. 5, 327-349. doi: 10.1146/annurev-food-030713-092415.
9. Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., et al. (2003). Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36, 592-598. doi: 10.1086/367653.
10. Gardete, S., and Tomasz, A. (2014). Mechanisms of vancomycin resistance in Staphylococcus aureus. J. Clin. Invest. 124, 2836-2840. doi: 10.1172/JCI68834.
11. Ginsburg, I. (2002). Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2, 171-179. doi: 10.1016/S1473-3099(02)00226-8.
12. Gutierrez, D., Vandenheuvel, D., Martinez, B., Rodriguez, A., Lavigne, R., and Garcia, P. (2015). Two phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono-and dual-species Staphylococcal biofilms. Appl. Environ. Microbiol. 81, 3336-3348. doi: 10.1128/AEM.03560-14.
13. Han, J. E., Kim, J. H., Hwang, S. Y., Choresca, C. H. Jr., Shin, S. P., Jun, J. W., et al. (2013). Isolation and characterization of a Myoviridae bacteriophage against Staphylococcus aureus isolated from dairy cows with mastitis. Res. Vet. Sci. 95, 758-763. doi: 10.1016/j.rvsc.2013.06.001.
14. Horner, A. A., and Raz, E. (2003). Do microbes influence the pathogenesis of allergic diseases? building the case for Toll-like receptor ligands. Curr. Opin. Immunol. 15, 614-619. doi: 10.1016/j.coi.2003.09.021.
15. Hoshiba, H., Uchiyama, J., Kato, S., Ujihara, T., Muraoka, A., Daibata, M., et al. (2010). Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic potential. Arch. Virol. 155, 545-552. doi: 10.1007/s00705-010-0623-2.
16. Hsieh, S. E., Lo, H. H., Chen, S. T., Lee, M. C., and Tseng, Y. H. (2011). Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2. Appl. Environ. Microbiol. 77, 756-761. doi: 10.1128/AEM.01848-10.
17. Jonczyk, E., Klak, M., Miedzybrodzki, R., and Gorski, A. (2011). The influence of external factors on bacteriophages-review. Folia Microbiol. (Praha). 56, 191-200. doi: 10.1007/s12223-011-0039-8.
18. Kazmierczak, Z., Gorski, A., and Dabrowska, K. (2015). Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses 7:1667. doi: 10.3390/V7041667.
19. Kraushaar, B., Thanh, M. D., Hammerl, J. A., Reetz, J., Fetsch, A., and Hertwig, S. (2013). Isolation and characterization of phages with lytic activity against methicillin-resistant Staphylococcus aureus strains belonging to clonal complex 398. Arch. Virol. 158, 2341-2350. doi: 10.1007/s00705-013-1707-6.
20. Kwan, T., Liu, J., DuBow, M., Gros, P., and Pelletier, J. (2005). The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc. Natl. Acad. Sci. U.S.A. 102, 5174-5179. doi: 10.1073/pnas.0501140102.
21. Lasobras, J., Muniesa, M., Frias, J., Lucena, F., and Jofre, J. (1997). Relationship between the morphology of bacteriophages and their persistence in the environment. Water Sci. Technol. 35, 129-132. doi: 10.1016/S0273-1223(97)00247-3.
22. Lee, J. K., Luchian, T., and Park, Y. (2015). Effect of regular exercise on inflammation induced by drug-resistant Staphylococcus aureus 3089 in ICR mice. Sci. Rep. 5:16364. doi: 10.1038/srep16364.
23. Li, L., and Zhang, Z. (2014). Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle. Mol. Biol. Rep. 41, 5829-5838. doi: 10.1007/s11033-014-3457-2.
24. Li, Z. P., Li, J., Qu, D., Hou, Z., Yang, X. H., Zhang, Z. D., et al. (2015). Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents. J. Pharm. Pharmacol. 67, 573-582. doi: 10.1111/jphp.12343.
25. Lowy, F. D. (1998). Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532. doi: 10.1056/NEJM199808203390806.
26. Matsushiro, A., and Okubo, S. (1972). [New method of phage isolation]. Tanpakushitsu Kakusan Koso 17(Suppl.), 292-298.
27. Pajunen, M., Kiljunen, S., and Skurnik, M. (2000). Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J. Bacteriol. 182, 5114-5120. doi: 10.1128/JB.182.18.5114-5120.2000.
28. Pincus, N. B., Reckhow, J. D., Saleem, D., Jammeh, M. L., Datta, S. K., and Myles, I. A. (2015). Strain specific phage treatment for Staphylococcus aureus infection is influenced by host immunity and site of infection. PLoS ONE 10:e0124280. doi: 10.1371/journal.pone.0124280.
29. Plata, K., Rosato, A. E., and Wegrzyn, G. (2009). Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity. Acta Biochim. Pol. 56, 597-612.
30. Prigent, M., Leroy, M., Confalonieri, F., Dutertre, M., and DuBow, M. S. (2005). A diversity of bacteriophage forms and genomes can be isolated from the surface sands of the Sahara Desert. Extremophiles 9, 289-296. doi: 10.1007/s00792-005-0444-5.
31. Sasidharan, S., Prema, B., and Yoga, L. L. (2011). Antimicrobial drug resistance of Staphylococcus aureus in dairy products. Asian Pac. J. Trop. Biomed. 1, 130-132. doi: 10.1016/S2221-1691(11)60010-5.
32. Son, J. S., Kim, E. B., Lee, S. J., Jun, S. Y., Yoon, S. J., Kang, S. H., et al. (2010). Characterization of Staphylococcus aureus derived from bovine mastitis and isolation of two lytic bacteriophages. J. Gen. Appl. Microbiol. 56, 347-353. doi: 10.2323/jgam.56.347.
33. Sulakvelidze, A., Alavidze, Z., and Morris, J. G. Jr. (2001). Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659. doi: 10.1128/AAC.45.3.649-659.2001.
34. Takemura-Uchiyama, I., Uchiyama, J., Osanai, M., Morimoto, N., Asagiri, T., Ujihara, T., et al. (2014). Experimental phage therapy against lethal lung-derived septicemia caused by Staphylococcus aureus in mice. Microbes Infect. 16, 512-517. doi: 10.1016/j.micinf.2014.02.011.
35. Viscardi, M., Perugini, A. G., Auriemma, C., Capuano, F., Morabito, S., Kim, K. P., et al. (2008). Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Int. J. Antimicrob. Agents 31, 152-157. doi: 10.1016/j.ijantimicag.2007.09.007.
36. Wang, Z., Guo, C., Xu, Y., Liu, G., Lu, C., and Liu, Y. (2014). Two novel functions of hyaluronidase from Streptococcus agalactiae are enhanced intracellular survival and inhibition of proinflammatory cytokine expression. Infect. Immun. 82, 2615-2625. doi: 10.1128/IAI.00022-14.
37. Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., et al. (2007). Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51, 446-452. doi: 10.1128/AAC.00635-06.
38. Wills, Q. F., Kerrigan, C., and Soothill, J. S. (2005). Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother. 49, 1220-1221. doi: 10.1128/AAC.49.3.1220-1221.2005.